Literature DB >> 29288209

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis.

Young Ho Lee1, Gwan Gyu Song2.   

Abstract

Entities:  

Keywords:  disease activity; giant cell arteritis; treatment

Mesh：

Substances：

Year:  2017        PMID： 29288209     DOI： 10.1136/annrheumdis-2017-212838

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  2 in total

1.  Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial.

Authors:  Arsene Mekinian; David Saadoun; Eric Vicaut; Sara Thietart; Bertrand Lioger; Patrick Jego; Alexandre Bleibtreu; Nicolas Limal; Jerome Connault; Jacques-Eric Gottenberg; Pauline Lhorte; Jean Pierre Bertola; Juliette Delforge; Nicole Ferreira-Maldent; Antoinette Perlat; Zohra Talib; Matthieu Vautier; Léa Savey; Isabelle Quiere; Patrice Cacoub; Olivier Fain
Journal:  Arthritis Res Ther       Date:  2020-09-17       Impact factor: 5.156

Review 2.  Efficacy of tocilizumab for refractory Takayasu arteritis: a retrospective study and literature review.

Authors:  Haiyan Li; Zongwen Shuai
Journal:  Heart Vessels       Date:  2021-11-08       Impact factor: 2.037
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.